Introduction: Glomus tumors (GTs) are uncommon tumors that often appear as a single lesion in the subungual region. Multiple GT is a rare clinical entity that can be associated with other diseases or in the context of genetic mutations. However, the occurrence of solitary GTs simultaneously has also been reported rarely.
Presentation Of Case: A 37-year-old lady with a history of cold sensitivity reported having pain in her right middle and ring fingers for several years. All paraclinical examinations were normal, and the patient underwent surgery based on clinical findings suggestive of a possible diagnosis of a GT, and the patient's pain was entirely resolved following tumor excision.
Discussion: GT should always be included in the differential diagnosis for multiple painful lesions.
Conclusion: Early diagnosis and appropriate treatment of a GT can prevent bothersome chronic pain for the patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijscr.2024.110724 | DOI Listing |
Cancer Rep (Hoboken)
January 2025
Department of Dermatology, the Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu, China.
Background: Glomus tumors are rare, benign mesenchymal neoplasms predominantly located in subungual regions of the extremities. Their occurrence in the mandibular region is exceptionally uncommon, presenting unique diagnostic challenges. Only a limited number of submandibular glomus tumors have been documented, leaving their presentation and management largely underexplored.
View Article and Find Full Text PDFClin Nucl Med
November 2024
From the Department of Nuclear Medicine, Ankara Etlik City Hospital, Ankara, Turkiye.
A 39-year-old woman with bilateral carotid body tumors was referred to 68Ga-DOTATATE PET/CT for further evaluation. Unknown metastatic sites with increased 68Ga-DOTATATE uptake were detected in the left cervical lymph node, liver, and bone. Carotid body paragangliomas (CBPs) represent less than 0.
View Article and Find Full Text PDFInt J Surg Case Rep
January 2025
Department of Otolaryngology-Head and Neck Surgery, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Introduction: Glomus tympanicum is a benign tumor classified under the group glomus tumors, and is also known as paragangliomas.
Case Presentation: A 52 years old woman presented with unilateral pulsatile tinnitus and hearing loss. She had a visible reddish mass behind the eardrum; Temporal bone CT scans suggested middle ear mass secondary to Glomus Tympanicum tumors.
Lasers Surg Med
December 2024
Department of Dermatology, Veterans Health Administration, San Antonio, Texas, USA.
Objectives: Glomangiomas are benign vascular malformations that exist within the spectrum of glomuvenous malformations which consist of varying amounts of glomus cells, vascular spaces, and smooth muscle. Glomangiomas are often treated due to associated pain, particularly when located on pressure areas such as the back or extensor surfaces, which can cause difficulty with certain activities and occupational functions. Histologically glomangiomas consist of prominent dilated vascular spaces lined by glomus cells typically situated in the deep-dermis to subcutaneous fat which limits treatment to modalities capable of reaching the depth of the tumor including excision, sclerotherapy, and laser therapy.
View Article and Find Full Text PDFAm J Surg Pathol
December 2024
Department of Pathology, Indiana University School of Medicine, Indianapolis, IN.
Juxtaglomerular cell tumor (JxGCT) is a rare type of renal neoplasm demonstrating morphologic overlap with some mesenchymal tumors such as glomus tumor (GT) and solitary fibrous tumor (SFT). Its oncogenic drivers remain elusive, and only a few cases have been analyzed with modern molecular techniques. In prior studies, loss of chromosomes 9 and 11 appeared to be recurrent.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!